Dr. Ranadeep Reddy Mandhadi, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 660 Summit Crossing Pl Ste 302, Gastonia, NC 28054 Phone: 704-671-6438 Fax: 704-671-6436 |
George Ayo Oluwa Korede, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 660 Summit Crossing Pl Ste 302, Gastonia, NC 28054 Phone: 704-671-6438 Fax: 704-671-6436 |
Dr. Rinku M Bhatia, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2240 Remount Road, Gastonia, NC 28054 Phone: 704-834-2450 Fax: 704-671-5331 |
Dr. Louis John Dalessandro, D.O. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2711 X Ray Dr, Gastonia, NC 28054 Phone: 704-671-6438 Fax: 704-671-6436 |
News Archive
It's not that younger people are able to remember more than older people. Their memories seem better because they are able to retrieve them in higher definition. So says Philip Ko of Vanderbilt University in the US, in a study that sheds light on how differences in the behavioral and neural activity of younger and older adults influence the different generations' ability to store and recall memories.
Safeguard Security Holdings, Inc., a provider of corporate, industrial and residential security solutions, announces that its Premier Background Search (PBS), a SEARCHglobal partnership (www.PBS-USA.com), has officially launched its marketing program to the massive healthcare market and has subscribed Martin Fletcher and Associates (www.medfuture.com) as its first major client for PBS' medical division.
Daylight Solutions, Inc., a leading manufacturer of molecular detection and imaging solutions in the mid-infrared, today announced the launch of the world's first commercially available laser-based infrared microscopy platform.
MicuRx Pharmaceuticals, Inc., a privately-held biopharmaceutical company developing next-generation antibiotics, today announced that it has filed an Investigational New Drug (IND) application with the State Food and Drug Administration (SFDA) in China for MRX-I, its first development-stage antibiotic drug candidate. MRX-I, an orally-administered oxazolidinone, targets multi-drug resistant Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).
› Verified 7 days ago